Inhibitor Potency Comparison
Inhibitor Potency Comparison - Related Videos
08:06
Automated Acoustic Dispensing for the Serial Dilution of Peptide Agonists in Potency Determination Assays
0 Views •
Cited by 1 •
2016
Peptide adsorption to plasticware during traditional tip-based serial dilutions can significantly impact potency determination and confound the understanding of structure-activity relationships used for lead identification and lead optimization phases of drug discovery. Here methods for automated acoustic non-contact serial dilution of peptide samples are described.
16:07
Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody (mAb) by Neutralizing TNF Using an In Vitro Bioanalytical Method
0 Views •
Cited by 1 •
2017
A protocol for the determination of the relative anti-apoptotic activity of an anti-TNFα mAb using a neutralization mechanism with WEHI 164 cells is presented here. This protocol is useful for comparing the neutralization strength of different molecules with the same biological functionality.
01:52
Eukaryotic Transcription Inhibitors
0 Views •
2020
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells. Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
08:45
Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
0 Views •
Cited by 4 •
2020
The ability to assess target engagement by candidate inhibitors in intact cells is crucial for drug discovery. This protocol describes a 384 well format cellular thermal shift assay that reliably detects cellular target engagement of inhibitors targeting either wild-type SHP2 or its oncogenic variants.
03:11
A Real-Time In Vitro Cytolysis Assay to Evaluate the Potency of CAR T Cells
0 Views •
2025
This video demonstrates a method for monitoring CAR T cell activity against cancer cells through real-time electrical impedance measurements. Tracking changes in impedance assesses the effectiveness of CAR T cells in inducing cancer cell cytolysis, providing insights into their cytotoxic capabilities.
FAQs
Matched conditions make differences between compounds more interpretable because measured potency depends on factors beyond the inhibitor itself. Substrate concentration, target abundance, and experimental design can shift the observed response. Holding these variables consistent allows researchers to attribute changes in concentration-response behavior more confidently to chemical differences rather than to variation in the assay setup.
Substrate concentration and target abundance can alter the apparent response produced by an inhibitor, so the same compound may not yield an identical potency value in every experiment. These variables matter when comparing compounds because unequal conditions can make one inhibitor appear more or less effective for reasons unrelated to its intrinsic chemical properties or binding behavior.
IC50 identifies the concentration associated with 50% inhibition under a defined assay, whereas Ki is an inhibition constant used to reflect binding strength. They therefore describe related but different aspects of inhibitor performance. Comparing either value requires attention to the assay conditions and experimental design, since the reported number gains meaning from how it was measured.
A concentration-response relationship shows how inhibition changes across tested concentrations rather than describing activity at only one point. This broader pattern supports estimation of comparison metrics such as IC50 and helps distinguish compounds with different response profiles. In chemistry, generating these relationships under defined conditions provides a quantitative basis for ranking candidate inhibitors.
A basic comparison begins by testing compounds across concentrations in an assay that measures activity of the selected target. Researchers then examine the resulting concentration-response relationships and determine an appropriate potency metric, such as IC50 or Ki. Keeping substrate, target, and design conditions defined and consistent makes the resulting comparison more meaningful.
In structure-activity relationship studies, potency measurements connect chemical changes in a compound series with changes in inhibitory performance. Comparing values under standardized assay conditions helps researchers identify which structural differences are associated with stronger or weaker activity. This information supports systematic compound optimization rather than relying only on qualitative observations of target inhibition.
The approach is useful when screening compounds for activity, investigating how candidate inhibitors affect a target, or selecting molecules for further study. Potency metrics provide a quantitative way to compare candidates and can contribute to mechanism-of-action research. In pharmaceutical and biochemical applications, these comparisons also support efforts to optimize selective inhibitors.